Steven Cohen Chemo Centryx, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $4.96 Million - $10.9 Million	-269,600 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.18 - $19.83 $3.55 Million - $5.35 Million	269,600 New	269,600 $4.61 Million
Q4 2020 Feb 16, 2021	SELL	$47.25 - $65.16 $32.1 Million - $44.3 Million	-679,281 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$46.35 - $61.69 $25.8 Million - $34.3 Million	555,696 Added 449.65%	679,281 $37.2 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $65.07 $2.72 Million - $4.58 Million	70,449 Added 132.58%	123,585 $7.11 Million
Q1 2020 May 15, 2020	BUY	$32.73 - $50.78 $1.74 Million - $2.7 Million	53,136 New	53,136 $2.14 Million
Q2 2019 Aug 14, 2019	SELL	$8.31 - $14.85 $3.32 Million - $5.94 Million	-400,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$10.01 - $13.89 $4 Million - $5.56 Million	400,000 New	400,000 $5.56 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.